Clinical studies recruiting near Brampton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · William Osler Health System ( Site 0103) · Merck Sharp & Dohme LLC · NCT06136559 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · William Osler Health Centre - Brampton Civic Hospital · Hoffmann-La Roche · NCT06793215 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Centricity Research Brampton · Amgen · NCT07037433 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · William Osler Cancer Centre · Agendia · NCT03053193 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · William Osler Health System ( Site 0101) · Merck Sharp & Dohme LLC · NCT06077760 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Centricity Research (Brampton) · Boehringer Ingelheim · NCT06531824 Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Mu
Phase 3 · William Osler Health System · Canadian Cancer Trials Group · NCT06182774 A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR
Phase 2 · William Osler Health System - Brampton Civic Hospital · Taiho Oncology, Inc. · NCT05967689 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · William Osler Health System - Brampton Civic Hospital /ID# 2 · AbbVie · NCT04928846 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785 Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder
Phase 2 · Jonathan Giddes Medicine Professional Corporation · Protara Therapeutics · NCT05951179 Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Phase 2 · Research Site · AstraZeneca · NCT06526793 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Centricity Research Brampton Endocrinology · Hoffmann-La Roche · NCT07351058 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 Invisalign® System with Mandibular Advancement
NA · Discover Orthodontics · Align Technology, Inc. · NCT06651944 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Investigational Site Number : 1240014 · Sanofi · NCT07184931 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · William Osler Health System - Brampton Civic Hospital · Daiichi Sankyo · NCT06203210 CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
Phase N/A · William Osler Health System - Brampton Civic Hospital · University Health Network, Toronto · NCT04151342 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressur
Phase 3 · Aggarwal and Associates Ltd · Amgen · NCT07226765 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 2019 · Anthos Therapeutics, Inc. · NCT05712200 Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic N
Phase 3 · Research Site · AstraZeneca · NCT07291037 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
NA · William Osler Health System - Brampton Civic Hospital · Mayo Clinic · NCT06087224 Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Mon
Phase 3 · William Osler Health System - Brampton Civic Hospital · ImmunityBio, Inc. · NCT06745908 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · Brampton Civic Hospital | Oncology · Bayer · NCT06452277 Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)
Phase 3 · William Osler Health System · Bruyère Health Research Institute. · NCT07063862 Pan-Canadian Lung Cancer Observational Study (PALEOS)
Phase N/A · Milena (Lynn) Vicente · William Osler Health System · NCT04706754 Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge
Phase 2 · William Osler Health System · Mark Vincent · NCT04335292 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Centricity Research Brampton · Amgen · NCT07136012 A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirze
Phase 2 · Centricity Research Brampton Endocrinology · Eli Lilly and Company · NCT06897475

Look up another city

Look up another condition